The drug uses a clever strategy. Trifluridine is a "killer": it penetrates the DNA of a cancer cell and destroys it from the inside, stopping its division. However, the human liver destroys Trifluridine very quickly. This is where Tipiracil, the "guardian", comes into play. It blocks liver enzymes, allowing the "killer" to stay in the blood longer and destroy the tumor more effectively.
